glutathione pathway breast cancer

glutathione pathway breast cancer reduced and Glutathione Depletion and Stalwart Anticancer Activity of Metallotherapeutics Inducing Programmed Cell Amino acid metabolism in breast – glutathione epigenetic drug resistance A

Name: glutathione pathway breast cancer reduced and Glutathione Depletion and Stalwart Anticancer Activity of Metallotherapeutics Inducing Programmed Cell Amino acid metabolism in breast – glutathione epigenetic drug resistance A
Brand: usimagingnetwork.com
SKU: 38971729444
Price: 22.35 USD
Availability: InStock
Rating: 4.1341 (11 reviews)

glutathione epigenetic drug resistance A prismatic view of the epigenetic metabolic regulatory axis in breast cancer therapy Frontiers Epigenetic mechanisms of Role of Glutathione in Cancer: From Mechanisms to Therapies PMC MitoWorld Decoding ferroptosis for cancer therapy Nature Reviews Cancer Glutamine metabolism in breast cancer and possible therapeutic targets ScienceDirect Human cancer associated fibroblasts enhance glutathione levels and antagonize drug induced prostate cancer cell death Cell Death & Disease

SKU: 38971729444 · From usimagingnetwork.com

4.1

USD22.35 USD47.35

Pay in 4 interest-free payments of $5.59 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Jul 30 - Aug 4

Description

Sangeetha et al

F1000Research 5:1748 Listos J, Baranowska-Bosiacka I, Talarek S, Listos P, Orzelska J, Fidecka S, Gutowska I, Kolasa A, Rybicka M, Chlubek D (2013) The effect of perinatal lead exposure on dopamine receptor D2 expression in morphine dependent rats

N-acetylcysteine (NAC) protects neurons from iron-induced ferroptosis by reducing free radical production, thereby reducing neuronal mortality (Kamel et al., 2024)

Since covalent binding of FA to rGO can produce stable and biocompatible materials with potential as a nanocarrier in the drug delivery system 87 , this is the first study that explores using FA-rGO as a carrier for BSA/AuNCs in the detection of GSH